Healthcare - Biotechnology - NASDAQ - US
$ 0.0001
0 %
$ 4.46 K
Market Cap
0.0
P/E
INCOME STATEMENT
0
REVENUE
-30 M
OPERATING INCOME
-30.4 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Aridis Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 30 M |
| Operating Income | -30 M |
| Other Expenses | 378 K |
| Net Income | -30.4 M |
Income Statement
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 1.0 | 1.0 | 2.8 | 0.9 | 2.3 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 1.9 |
| Gross Profit | 0 | 0 | 1.0 | 1.0 | 2.8 | 0.9 | 0.3 |
| OPERATING INCOME | |||||||
| Operating Expenses | 30.0 | 43.7 | 23.4 | 30.1 | 26.9 | 20.6 | 8.2 |
| Selling, General and Administrative Expenses | 7.2 | 7.3 | 6.4 | 6.0 | 3.9 | 3.2 | 2.0 |
| Research and Development Expenses | 25.9 | 37.9 | 17.0 | 24.1 | 23.0 | 17.4 | 6.3 |
| Operating Income | (30.0) | (43.7) | (22.4) | (29.1) | (24.1) | (19.7) | (7.9) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0.4 | (0.2) | 0 | 0 | 0.4 | 0 | 0.4 |
| Total Other Income | (0.4) | 1.5 | 68 K | (0.6) | 2.0 | (4.9) | (0.5) |
| Pre-Tax Income | (30.4) | (43.2) | (22.3) | (29.7) | (22.1) | (24.7) | (8.4) |
| NET INCOME | |||||||
| Tax Provision | 0.4 | (0.9) | (0.4) | (0.7) | 2.4 | 4.9 | 0.5 |
| Net Income | (30.7) | (42.3) | (21.9) | (29.0) | (22.1) | (24.7) | (8.4) |
| EPS | 1.64 | 3.44 | 2.39 | 3.43 | 7.02 | 3.12 | 1.07 |